Pfizer Inc (PFE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Pfizer Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
PFE Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- Pfizer Inc's percent of analysts bearish on the stock is less than just about 100% of all US stocks.
- Pfizer Inc's number of analysts covering the stock is higher than 7.69% of stocks in the mega market cap category.
- Pfizer Inc's upside potential (average analyst target price relative to current price) is greater than 11.92% of Pharmaceutical Products stocks.
- PFE has a greater percentage of analysts bullish on the stock than 14.36% of Pharmaceutical Products stocks.
- PFE has a higher average analyst price target than 17.31% of stocks in the mega market cap category.
- PFE has a lower variance in analysts' estimates than 33.65% of all US stocks.
- PFE has a lower change in bullishness amongst analysts than just about 100% of all US stocks.
What is the outlook for PFE? Use POWR Ratings for clearer insight into price direction.